Protein Overexpression and Gene Amplification of c-erbB-2 in Pulmonary Carcinomas: A Comparative Immunohistochemical and Fluorescence In Situ Hybridization Study
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (6) , 556-562
- https://doi.org/10.1038/modpathol.3880350
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factorEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerMolecular Carcinogenesis, 1992
- c-erbB-2 oncoprotein expression in primary human tumorsCancer, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancerBritish Journal of Cancer, 1989
- Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristicsCancer, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987